NICOLINI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 18.454
AS - Asia 11.712
EU - Europa 8.208
SA - Sud America 1.289
Continente sconosciuto - Info sul continente non disponibili 860
AF - Africa 225
OC - Oceania 33
Totale 40.781
Nazione #
US - Stati Uniti d'America 17.336
VN - Vietnam 3.683
SG - Singapore 3.268
CN - Cina 2.084
IT - Italia 2.051
DE - Germania 1.306
HK - Hong Kong 1.023
RU - Federazione Russa 1.010
BR - Brasile 986
CA - Canada 945
SE - Svezia 903
IE - Irlanda 685
UA - Ucraina 607
GB - Regno Unito 450
FR - Francia 320
IN - India 289
BD - Bangladesh 250
KR - Corea 231
FI - Finlandia 200
AT - Austria 143
TR - Turchia 124
ID - Indonesia 119
AR - Argentina 98
IQ - Iraq 97
NL - Olanda 90
JP - Giappone 77
ZA - Sudafrica 72
PK - Pakistan 71
DK - Danimarca 69
PL - Polonia 67
ES - Italia 66
MX - Messico 64
BE - Belgio 60
PH - Filippine 55
VE - Venezuela 47
SA - Arabia Saudita 46
EC - Ecuador 45
LT - Lituania 45
MY - Malesia 42
UZ - Uzbekistan 42
TW - Taiwan 36
CO - Colombia 34
AU - Australia 30
CH - Svizzera 29
CL - Cile 27
JM - Giamaica 27
KE - Kenya 26
MA - Marocco 26
CZ - Repubblica Ceca 18
IR - Iran 18
AE - Emirati Arabi Uniti 17
PY - Paraguay 17
EG - Egitto 16
JO - Giordania 16
CR - Costa Rica 15
LB - Libano 14
NP - Nepal 14
TN - Tunisia 14
AZ - Azerbaigian 13
HN - Honduras 12
PT - Portogallo 12
RO - Romania 12
DO - Repubblica Dominicana 11
EU - Europa 11
PE - Perù 11
AL - Albania 10
BG - Bulgaria 10
ET - Etiopia 10
IL - Israele 10
UY - Uruguay 10
AM - Armenia 9
BO - Bolivia 9
DZ - Algeria 9
GR - Grecia 9
TH - Thailandia 9
KZ - Kazakistan 8
NI - Nicaragua 8
PA - Panama 7
PR - Porto Rico 7
RS - Serbia 7
AO - Angola 6
HR - Croazia 6
KG - Kirghizistan 6
LY - Libia 6
NG - Nigeria 6
OM - Oman 6
PS - Palestinian Territory 6
SN - Senegal 6
GT - Guatemala 5
TT - Trinidad e Tobago 5
BF - Burkina Faso 4
CG - Congo 4
CI - Costa d'Avorio 4
HU - Ungheria 4
KW - Kuwait 4
MN - Mongolia 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
GE - Georgia 3
LK - Sri Lanka 3
Totale 39.869
Città #
Ann Arbor 1.956
Singapore 1.940
Ashburn 1.771
San Jose 1.347
Ho Chi Minh City 1.152
Hong Kong 1.002
Hanoi 895
Woodbridge 883
Frankfurt am Main 793
Chandler 782
Houston 781
Dallas 721
Milan 721
Dublin 670
Toronto 664
Jacksonville 595
Fairfield 497
Dearborn 458
New York 420
Santa Clara 402
Wilmington 355
Council Bluffs 341
Beijing 339
Los Angeles 291
Princeton 235
Boardman 232
Chicago 227
Hefei 204
Seattle 201
The Dalles 184
Seoul 175
Nanjing 155
Cambridge 148
Columbus 141
Shanghai 138
Lauterbourg 128
Vienna 125
Buffalo 121
Haiphong 121
Rome 121
São Paulo 102
Da Nang 100
Lachine 94
Biên Hòa 77
Ha Long 77
Helsinki 76
Lawrence 71
Moscow 71
Hải Dương 69
Altamura 65
Jakarta 64
Phoenix 61
Munich 59
Quận Bình Thạnh 59
Nanchang 56
Can Tho 53
Montreal 52
Atlanta 51
Ninh Bình 51
Orem 51
Tokyo 51
Fremont 50
Thái Nguyên 50
London 49
Warsaw 49
Brooklyn 48
Guangzhou 47
Brussels 45
Chennai 43
Andover 42
Ottawa 42
Saint Petersburg 42
Vũng Tàu 42
Bắc Giang 40
Bắc Ninh 40
Changsha 40
Dong Ket 40
Hebei 40
San Diego 40
Shenyang 40
Boston 38
Quận Một 38
Grafing 37
Quận Phú Nhuận 35
Rio de Janeiro 35
Tianjin 35
Jinan 34
Johannesburg 34
Tashkent 34
Turin 31
Mountain View 30
Phủ Lý 30
Baghdad 29
Dhaka 28
Falls Church 28
Figino 28
Kunming 28
Nuremberg 28
Jiaxing 27
Lissone 27
Totale 25.305
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.184
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 794
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 660
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 579
Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells 551
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 528
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 516
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 498
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 494
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 485
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 472
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 462
Stem cell augmented mesh materials: an in vitro and in vivo study 448
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 435
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 424
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 422
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 401
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 401
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 392
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 388
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 380
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 377
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 372
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 371
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 367
AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules 357
Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis 346
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 343
Role of MAPKs in platinum-induced neuronal apoptosis 338
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 326
Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent 326
In vitro anticancer activity and neurotoxicity of novel heavy metal-based anticancer complexes 319
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 317
OCT2 transporter involvement in development of cisplatin toxicity 316
Evaluation of in vitro antitumoral activity and neurotoxicity of a Hibiscus Sabdariffa ethyl acetate fraction against human multiple myeloma cells 316
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 314
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 310
Association between metalloproteinases 2 and 9 activity and ERK1/2 phosphorylation status in head and neck cancers: An ex vivo study 310
Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx 307
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 307
Breast radiotherapy with kilovoltage photons and gold nanoparticles as radiosensitizer: An in vitro study 307
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis 305
Neurotoxicity and photon activation therapy effect of new heavy metal-based anticancer complexes 305
The Role of NMNAT2/SARM1 in Neuropathy Development 304
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 304
Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis 304
Histological assessment of vaginal wall at different stages of pelvic organ prolapse 304
Intraepidermal nerve fiber density in rat foot pad: Neuropathologic- neurophysiologic correlation 302
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 297
Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells 295
Axonal transport impairment in chemotherapy-induced peripheral neuropathy 295
Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties 291
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 290
In vitro neuroprotective action of erythrpoietin against docetaxel and cisplatin induced neurotoxicity 290
Synchrotron-based photon activation therapy effect on cisplatin pre-treated human glioma stem-like cells 290
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 288
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 288
Antitumoral effects of Hibiscus Sabdarifa on human oral squamous cell carcinoma and multiple myeloma cells 287
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 285
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 282
Embryonic rat dorsal ganglia organotypic culture: a morphometric model to test neurotoxicology 281
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 278
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 270
Myricetin and Naringenin Inhibit Human Squamous Cell Carcinoma Proliferation and Migration In Vitro 270
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 269
Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line 267
Flavonoids in oral cancer prevention and therapy 266
MAP kinase modulation in squamous cell carcinoma of the oral cavity 265
RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY 264
Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells 264
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 263
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 263
Confocal laser scanning microscope and ultrastructural study of the intracellular localization of fluorescein-loaded mesoporous silica carriers 261
Emerging role of mitogen-activated protein kinases in peripheral neuropathies 260
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 260
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 259
Mechanisms of protection by low-dose cisplatin in paclitaxel-induced apoptosis in human neuroblastoma cell line SH-SY5Y 259
Copper(I) and Gold(I) phosphane complexes: biological activity, neurotoxicity an photon activation therapy effect 256
Heavy metal-based complexes: activity, neurotoxicity and photon activation therapy's effect in human tumour cells 255
Different stages of pelvis prolapse: morphologic and biochemical analysis of anterior vaginal wall 254
Chapter 10 In vitro neurotoxicity of antineoplastic agents 253
Human oral squamous cell carcinoma proliferation and migration prevented by two flavonoids 250
Equal increases in respiratory system elastance reflect similar lung damage in experimental ventilator-induced lung injury 248
Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity 248
Resveratrol, MAP kinases and neuronal cells: Might wine be a neuroprotectant? 245
Embryonic rat dorsal root ganglia organotypic culture: a reliable model to test neurotoxicity 240
Tecniche e strumenti di studio in ISTOLOGIA per le professioni sanitarie 239
Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF- α-mediated 237
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 237
The neuroprotective effect of erythropoietin (EPO) and of its non-erythropoietic carbamylated derivative (CEPO) in cisplatin-induced peripheral neurotoxicity 235
Immunocytochemical characterization of mesenchymal stem cells effect of DRG neurons apoptotic death 235
The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity 233
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 233
Molecular mechanisms involved in the supportive effect of MSCs on DRG dissociated neurons survival 232
Neurotrophin effect on the SH-SY5Y human neuroblastoma (HN) model of CDDP-induced neurotoxicity 229
In vitro neurotoxicity of new promising metal-based anticancer complexes 227
Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome 226
Neurotrophins: effect on cisplatin-induced cytotoxicity and neurotoxicity in SH-SY5Y cells 225
Resveratrol protects human neuroblastoma SH-SY5Y from paclitaxel-induced apoptosis 224
In vitro study of heavy metal-based anticancer complexes: activity, neurotoxicity and photon activation tharapy's effect 223
Totale 33.169
Categoria #
all - tutte 118.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.204 0 0 0 179 110 172 116 73 71 103 101 279
2022/20233.139 312 911 372 311 237 465 29 152 200 22 82 46
2023/20242.132 55 66 89 93 307 508 419 88 117 34 16 340
2024/20254.948 319 466 302 217 470 194 247 203 498 663 514 855
2025/202616.540 3.484 1.535 1.359 1.187 1.321 686 1.969 638 1.162 1.204 1.116 879
2026/20273.176 462 760 1.685 269 0 0 0 0 0 0 0 0
Totale 40.781